LabSense News Q1 2020 Edition

In this “Q1 2020 Edition”of BUHLMANN’s LabSense News, we are proud to introduce Quantum Blue® Anti-Infliximab (RUO) and Anti-Adalimumab (RUO) to the TDM rapid test portfolio. Check out a new video for Flow CAST® basophil activation test (BAT), view recent BÜHLMANN assay citations, and read an interesting white paper for our BÜHLMANN GanglioCombi® MAG ELISA.